Welcome to LookChem.com Sign In|Join Free
  • or
7-chloro-3-((2-(trimethylsilyl)ethoxy)methyl)-3H-imidazo[4,5-b]pyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

2098583-31-2

Post Buying Request

2098583-31-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2098583-31-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2098583-31-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,0,9,8,5,8 and 3 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2098583-31:
(9*2)+(8*0)+(7*9)+(6*8)+(5*5)+(4*8)+(3*3)+(2*3)+(1*1)=202
202 % 10 = 2
So 2098583-31-2 is a valid CAS Registry Number.

2098583-31-2Downstream Products

2098583-31-2Relevant academic research and scientific papers

PYRIDO OXAZINE AMINO DERIVATIVES AS ALK5 INHIBITORS

-

Paragraph 0427-0429, (2022/01/24)

The present invention relates to a compound of general formula (I) inhibiting the growth factor receptor transforming β (TGF-β) type I (ALK5), methods for preparing these compounds, pharmaceutical compositions containing them and their therapeutic use. The compounds according to the invention may be useful in the treatment of diseases or conditions associated with the disruption of the ALK5 signaling pathway in a mammal.

AZETIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF

-

Paragraph 0099; 0100, (2018/08/29)

The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, infl

COMPOUND, COMPOSITIONS, AND METHODS

-

, (2017/08/01)

Compounds having activity as LRRK2 inhibitors are disclosed. The compounds are of formula (I) including stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2098583-31-2